Assessing women's potential risk of developing breast cancer

ONCOLOGY

Volumn 10, Issue 10, 1996, Pages 1451-1458+1461

  Vogel, Victor G ^a,b  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOPSY; BREAST TUMOR; FEMALE; HUMAN; MAMMOGRAPHY; PEDIGREE; REVIEW; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL;

BIOPSY; BREAST NEOPLASMS; FEMALE; HUMANS; MAMMOGRAPHY; MODELS, STATISTICAL; PEDIGREE; RISK ASSESSMENT; RISK FACTORS;

EID: 0030254132     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Lilienfeld AM, Lilienfeld DE: Foundations of Epidemiology. New York, Oxford University Press 217:346-347, 1980.
2. Madigan MP, Ziegler RG, Benichou J, et al: Proportion of breast cancer cases in the United States explained by well-established risk factors. J Natl Cancer Inst 87:1681-1685, 1995.
3. Dawson DA, Thompson GB: Breast cancer risk factors and screening: United States, 1987. National Center for Health Statistics. Vital Health Stat 10(172), 1989.
4. Buell P: Changing incidence of breast cancer in Japanese-American women. J Natl Cancer Inst 51:1479-1483, 1973.
5. Harris JR, Lippman ME, Veronesi U, et al. Breast cancer. N Engl J Med 327:319-328, 1992.
6. Kelsey JL A review of the epidemiology of human breast cancer. Epidemiol Rev 1:74-109, 1979.
7. Kelsey JL, Berkowitz GS: Breast cancer epidemiology. Cancer Res 48:5615-5623, 1988.
8. Kelsey JL, Gammon MD: Epidemiology of breast cancer. Epidemiol Rev 12:228-240, 1990.
9. Kelsey JL, Gammon MD, John EM: Reproductive factors and breast cancer. Epidemiol Rev 15:36-47, 1993.
10. Daling JR, Malone KE, Voigt LF, et al: Risk of breast cancer among young women: relationship to induced abortion. J Natl Cancer Inst 86:1584-1592, 1994.
11. Black MM, Modan B, Lubin F, et al: A nationwide study of breast disease. Cancer 61:2547-2551, 1988.
12. Yu H, Rohan TE, Howe GR, et al Risk factors for fibroadenoma: A case-control study in Australia. Am J Epidemiol 135:247-258, 1992.
13. Millikan R, Hulka B, Thor A, et al: p53 mutations in benign breast tissue J Clin Oncol 13:2293-2300, 1995.
14. Vogel VG: High-risk populations as targets for breast cancer prevention trials. Prevent Med 20:86-100, 1991.
15. Gail MH, Brinton LA, Byar DP, et al: Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 81:1879-1886, 1989.
16. Dupont WD, Page DL: Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 312:146-151, 1985.
17. Page DL, Dupont WD, Rogers LW, et al: Atypical hyperplastic lesions of the female breast: A long-term follow-up study. Cancer 55:2698-2708, 1985.
18. Carter CL, Corle DK, Micozzi MS, et al: A prospective study of the development of breast cancer in 16,692 women with benign breast disease. Am J Epidemiol 128:467-477, 1988.
19. London SJ, Connolly JL, Schnitt SJ, et al: A prospective study of benign breast disease and the risk of breast cancer. JAMA 267:941-944, 1992.
20. Dupont WD, Parl FF, Hartman WH, et al: Breast cancer risk associated with proliferative disease and atypical hyperplasia. Cancer 71:1258-1265, 1993.
21. Rubin E, Visscher DW, Alexander RW, et al: Proliferative disease and atypia in biopsies performed for nonpalpable lesions detected mammographically. Cancer 61:2077-2082, 1988.
22. Jensen RA, Page DL, Dupont WD, et al: Invasive breast cancer risk in women with sclerosing adenosis. Cancer 64:1977-1983, 1989.
23. Claus EB, Risch N, Thompson WD: Genetic analysis of breast cancer in the Cancer and Steroid Hormone Study. Am J Hum Genet 48:232-242, 1989.
24. Hoskins KF, Stopfer JE, Calzone KA, et al: Assessment and counseling for women with a family history of breast cancer: A guide for clinicians JAMA 273:577-585, 1995.
25. Slattery ML, Kerber RA: A comprehensive evaluation of family history and breast cancer risk - the Utah population database. JAMA 270:1563-1568, 1993.
26. Claus EB, Risch N, Thompson WD: Autosomal dominant inheritance of early-onset breast cancer: Implications for risk prediction. Cancer 73:643-651, 1994.
27. Anderson DE, Badzioch MD: Risk of familial breast cancer. Cancer 56:383-387, 1985.
28. Easton DF, Bishop DT, Ford D, et al and the Breast Cancer Linkage Consortium: Genetic linkage analysis in familial breast and ovarian cancer: results for 214 families. Am J Human Genet 52:678-701, 1993.
29. Miki Y, Swensen J, Shattuck-Eidens D, et al: A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66-71, 1994.
30. Merajver SD, Pham TM, Caduff RF, et al: Somatic mutations in the BRCA1 gene in sporadic ovarian tumors. Nat Genet 9:439-443, 1995.
31. Thompson ME, Jensen RA, Obermiller PS, et al: Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nature Genet 9:444-450, 1995.
32. Holt JT, Thompson ME, Szabo C, et al: Growth retardation and tumor inhibition by BRCA1. Nature Genet 12:298-302, 1996.
33. Easton DF, Ford BP, Bishop DT, and the Breast Cancer Linkage Consortium: Breast and ovarian cancer incidence in BRCA1-mutation carriers. Am J Hum Genet 56:265-271, 1995
34. Stratton M, Ford DF, Bishop DT, et al: Familial male breast cancer is not linked to the BRCA1 locus on chromosome 17q. Nature Genet 7:103-107, 1994.
35. Wooster R, Neuhausen SL, Mangion J: Localization of breast cancer susceptibility gene BRCA2 to chromosome 13q12-13. Science 265:2088-2090, 1994.
36. Offit K, Brown K: Quantitation of familial cancer risk: A resource for clinical oncologists. J Clin Oncol 12:1724-1736, 1994.
37. Peters J: Breast cancer genetics: Relevance to oncology practice. Cancer Control 2:195-208, 1995.
38. Nayfield SG, Karp JE, Ford LG, et al: Potential role of tamoxifen in prevention of breast cancer. J Natl Cancer Inst 83:1450-1459, 1991.
39. Benichou J, Gail MH, Mulvihill JJ: Graphs to estimate an individualized risk of breast cancer. J Clin Oncol 14:103-110, 1996.
40. Spiegelman D, Colditz GA, Hunter D, et al: Validation of the Gail et al model predicting individual breast cancer risk. J Natl Cancer Inst 86:600-607, 1994.
41. Bondy ML, Lustbader ED, Halabi S, et al: Validation of a breast cancer risk assessment model in women with a positive family history. J Natl Cancer Inst 86,620-625, 1994.
42. Vogel VG, Yeomans A, Higginbotham E: Clinical management of women at increased risk for breast cancer. Breast Cancer Res Treat 28:195-210, 1993.
43. Vogel VG: Counseling the high-risk woman, in Stoll BA, (ed): Reducing Breast Cancer Risk in Women, pp 69-80. Boston, Kluwer Academic Publishers, 1995.
44. Black WC, Nease RF Jr, Tosteson ANA: Perceptions of breast cancer risk and screening effectiveness in women younger than 50 years of age. J Natl Cancer Inst 87:720-731, 1995.
45. Lerman C, Rimer BK, Engstrom PF: Cancer risk notification: Psychological and ethical implications. J Clin Oncol 9:1275-1282, 1991.
46. Lerman C, Rimer B, Trock B, et al: Psychological and behavioral implications of abnormal mammograms. Ann Intern Med 114:657-661, 1991.
47. Lerman C, Trock B, Rimer B, et al: Psychological side-effects of breast cancer screening. Health Psychol 10:259-267, 1991.
48. Kash JM, Holland JC, Halper MS, et al: Psychological distress and surveillance behaviors of women with a family history of breast cancer. J Natl Cancer Inst 84:24-30, 1992.
49. Vogel VG, Graves DS, Vernon SW, et al: Mammographic screening of women with increased risk of breast cancer. Cancer 66:1613-1620, 1990.
50. Lerman C, Schwartz M: Adherence and psychological adjustment among women at high nsk for breast cancer. Breast Cancer Res Treat 28:145-155, 1993.
51. Alagna SW, Morokoff PJ, Bevett JM, et al: Performance of breast self-examination by women at high risk for breast cancer. Women Health 12:29-46, 1987.
52. Lerman C, Rimer B, Trock B, et al: Factors associated with repeat adherence to breast cancer screening Prev Med 19:279-290, 1990.